Company Profile
Updated: 27-OCT-09DiaGenic ASA
International public company
Grenseveien 92, Oslo, N-0663, Norway
()47 23 24 89 50, 47 23 24 89 59 fax, http://www.diagenic.com
Primary SIC: In Vitro & In Vivo Diagnostic Agents, Primary NAICS: In-Vitro Diagnostic Substance Manufacturing
Description: Manufacturing: Biotechnology company which develops diagnostic tests for early detection of breast cancer and Alzheimer's based on gene expression signatures in blood.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Norwegian DiaGenic completes NOK34.4m private placement.
Nordic Business Report; 11/26/2009; 509 words; ...26 November 2009-Norwegian DiaGenic completes NOK34.4m private placement...Norwegian biotechnology company DiaGenic ASA (OSL: DIAG) said today it raised...The transaction aimed to finance DiaGenic's operating costs and to strengthen...
Norwegian DiaGenic raises EUR 4.1m in private placement.
ADP News Nordic; 11/26/2009; 505 words; ...Norwegian biotechnology company DiaGenic ASA (OSL:DIAG) said today it raised...The transaction aimed to finance DiaGenic's operating costs and to strengthen...75. The board of directors in DiaGenic has decided to propose the issuance...
Other News To Note.
BIOWORLD Today; 11/3/2009; 3240 words; ...product in Phase I development for cervical cancer. o DiaGenic ASA, of Oslo, Norway, said results of a study into the...accurately diagnosed in at least 82 percent of patients. DiaGenic said the genes are not specifically cancer genes or...
Norwegian DiaGenic signs distribution deal for UK, Ireland.
ADP News Nordic; 10/29/2009; 463 words; ...Oct 29, 2009 - Norwegian biotechnology company DiaGenic ASA (OSL:DIAG) said today that it has signed distribution...and Ireland. No financial details were available. DiaGenic's partner is an unnamed leading provider of diagnostic...
Norwegian DiaGenic lacks money.
ADP News Nordic; 8/21/2009; 479 words; ...Norwegian biotechnology company DiaGenic ASA (OSL:DIAG) said today had no...year. At the end of June 2009, DiaGenic had NOK 8.1 million (USD 1...interim report. In early July, DiaGenic secured bridge financing by raising...
Recent News Articles
- DiaGenic ASA Presents Prototypes of the First Early Bloodtest for Alzheimer's Disease at AD/PD 2007.
Business Wire - March 16, 2007 - DiaGenic ASA 2007 Entrepreneurial Company of the Year Award on DiaGenic ASA in the European Molecular Diagnostics Market.
PR Newswire - March 12, 2007 - Parkinson's Diagnosis Breakthrough: DiaGenic ASA Presents Test Data at European IPA Meeting in Lisbon.
Business Wire - May 10, 2006 - Blood Test to Detect Alzheimer's a Step Closer; Second Study Confirms DiaGenic ASA's Breakthrough Test Method for Alzheimer's Disease.
Business Wire - February 13, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning